<DOC>
	<DOCNO>NCT01198457</DOCNO>
	<brief_summary>Adherence ( compliance ) medication regimen generally define extent patient take medication prescribe health care provider . The adherence medication close relation effectiveness therapy . The primary objective study observe adherence treatment oral clodronate ( PDC , proportion day cover , number day clodronate take accord treat physician recommendation ) patient malignancy . The secondary `` hypothesis generating '' objective describe relation adherence treatment oral clodronate efficacy therapy ( skeletal event , pain ) .</brief_summary>
	<brief_title>Study Investigate Adherence Patients Clodronate ( Bonefos ) Treatment</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Osteolysis</mesh_term>
	<mesh_term>Clodronic Acid</mesh_term>
	<criteria>Diagnosis breast cancer , prostate cancer , multiple myeloma skeletal event cause tumor Bone metastases Therapy clodronate ( 1600 mg per day , 800 mg tablet ) accord SmPC ( Summary Product Characteristics ) Bonefos . By agree usage patient diary goodwill account tablet According SmPC ( Summary Product Characteristics ) Bonefos .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Clodronate</keyword>
	<keyword>Compliance</keyword>
</DOC>